The strong activation of Drp1, leading to enhanced mitochondrial fission, has been frequently discussed in the context of HCC, where it promotes de novo fatty acid synthesis in liver cancer cells, suggesting a potential target for therapeutic intervention43,44. Here, DNM1L is linked to hepatocellular carcinoma.